If you have been reading about freeze-thaw cycling and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Analytical checks can detect changes in a reconstituted stock over time. Reverse-phase high-performance liquid chromatography can show loss of main peak, new impurity peaks, or altered retention. Mass spectrometry confirms molecular identity and can reveal modifications. Visual inspection for particles, color change, or turbidity provides a simple first check. If a solution shows signs of degradation or contamination, it is typically discarded rather than re-purified in a routine laboratory.
Once a peptide is dissolved, its solution is generally less stable than the dry powder. Chemical pathways such as hydrolysis, oxidation, and deamidation can alter the molecule, while physical processes can form aggregates or cause adsorption to container walls. The rate depends on pH, buffer composition, temperature, concentration, and the specific sequence. Aqueous stocks are therefore kept cold and used within a defined period. Stability testing is usually performed for each peptide rather than assumed from a general rule.
Cold storage slows most degradation but does not stop it. Reconstituted solutions are commonly divided into aliquots and held at -20 °C or -80 °C, depending on the peptide. Repeated freeze-thaw cycles can promote aggregation or precipitation, so single-use aliquots are preferred. Some peptides tolerate refrigeration for short intervals, while others require freezing immediately. Light-sensitive residues may need amber or foil-wrapped containers. The optimal condition remains peptide-specific and should be supported by stability data.
Storage stability of a reconstituted peptide depends on concentration, pH, buffer composition, and the presence of oxygen or microbial contaminants. Short-term storage is often at refrigerated temperatures, while longer-term storage may use freezing at -20 °C or -80 °C. Repeated warming and cooling can cause losses through adsorption or aggregation, so aliquots are preferred. Light-sensitive peptides require protection from ambient light. Sterile filtration may be used when microbial control is needed, but filters can adsorb peptides and reduce recovery.
Quality control after reconstitution usually includes visual inspection and instrumental analysis. A clear, particle-free solution is generally expected, but color and clarity can vary with sequence and buffer. Chromatographic separation can detect degradation products, while mass confirmation verifies molecular identity. pH measurement and osmolality checks may be relevant for certain applications. Documentation of lot number, solvent, and storage history supports reproducibility and helps distinguish preparation artifacts from sample degradation. Temperature logs and freeze-thaw counts add further context when results are reviewed.
After a peptide solution is prepared, its handling conditions influence how long it remains suitable for use. Solutions are typically separated into small portions to avoid repeated freeze-thaw cycles, which can promote aggregation or precipitation. Containers are chosen to minimize adsorption, especially for peptides that are hydrophobic or present at low concentration. Some laboratories use low-binding plastic tubes or add a carrier protein, although carrier addition can interfere with later analysis. Records usually note the solvent, date, and storage temperature for traceability.
| Property | Value | Notes |
|---|---|---|
| Storage temperature (reconstituted) | -20 °C to -80 °C | Exact condition depends on peptide, solvent, and stability data |
| Freeze-thaw stability | Limited number of cycles | Repeated cycles can increase aggregation and precipitation |
| Common degradation pathways | Hydrolysis, oxidation, deamidation | Relative rates depend on sequence, pH, and buffer |
| Container material | Low-binding polypropylene | Reduces adsorption loss for some peptides |
| Analytical method for stability | Reverse-phase HPLC | Monitors main peak loss and formation of impurity peaks |
In early 2022 a promotional video was shot with influencer Niko Omilana showing a chicken farm in the KFC supply chain. The video depicted birds with a good quality of life. Animal rights activists, working on behalf of the vegan food brand VFC, entered the same farm months later and allegedly found vastly different conditions, with instances of "severe overcrowding" and "lame and dead birds". A spokesperson for the Moy Park meat company who operated the farm said: "Claims such as these are treated incredibly seriously and we immediately reviewed the footage along with independent audits and veterinary reports. This farm is managed to a very high standard and our preliminary findings show that it is meeting those standards." On November 9, 2022, KFC Germany issued an announcement inviting its German audience to celebrate Kristallnacht with "Cheesy Chicken". An apology was issued shortly afterwards, blaming the original message as an "error in our system". In May 2024, the closure of the outlet in Malaysia was reported due to the ongoing Israeli–Palestinian conflict. Attacks on two outlets in Baghdad, Iraq were also reported. In September 2024, KFC announced that it would not meet the Better Chicken Commitment, an animal welfare pledge made in 2019. The commitment includes several welfare standards, such as adopting slower-growing breeds by 2026, but as of 2024, only 1% of KFC's chickens were from such breeds.
== Description == The fruiting body is varying in size, and can be 5–30 centimetres (2–12 in) tall and 4–20 cm (1+1⁄2–8 in). Immatures have been described to be oblong, somewhat resembling the shape of a rugby ball. There is some variation in coloration, and mature Pisolithus Arhizus feature a shiny gray/brown shell with darker and lighter/whitish/yellowish patches depending on the specimen. As it ages, the fungus can develop a rudimentary stipe or stem, although not all will do this. It also tends to open up, exposing "cracks and fissures, and eventually breaking up to expose the interior." This outer peridium is roughly 1mm thick and within it can be found a mass of pea-sized "pseudoperidioles" which are structures that contain and produce spores, and are fixed in a dark gel. As a reproductive strategy, P.arhizus will release spores to the wind as the peridium turns dry and crumbly/powdery with time. The fungus has non-ornamental spores that are described as "khaki" or "cinnamon" brown, and measure roughly 5-8µm in size.
UniProt is an online repository of protein sequence and annotation data, distributed in UniProt Knowledgebase (UniProt KB), UniProt Reference Clusters (UniRef) and UniProt Archive (UniParc) databases. Originally conceived as the individual ventures of EMBL-EBI, Swiss Institute of Bioinformatics (SIB) (together maintaining Swiss-Prot and TrEMBL) and Protein Information Resource (PIR) (housing Protein Sequence Database), the increase in the global protein data generation led to their collaboration in the creation of UniProt in 2002. The protein entries stored in UniProt are cataloged by a unique UniProt identifier. The annotation data collected for the each entry are organized in logical sections (e.g. protein function, structure, expression, sequence or relevant publications), allowing a coordinated overview about the protein of interest. Links to external databases and original sources of data are also provided. In addition to standard search by the protein name/identifier, UniProt webpage houses tools for BLAST searching, sequence alignment or searching for proteins containing specific peptides.
The entries in BTO are updated bi-annually as part of the major update of BRENDA. It is available via the BRENDA website in the category “Ontology Explorer”. The enzyme source terms can be searched via the BTO query form. As a result, the user receives a list of EC numbers which are directly connected to the enzyme information of BRENDA. It is also possible to search via the BRENDA “Source Tissue” search form (“Classic View”). The result page displays all enzymes which are isolated or detected in the searched tissue term, directly linked to BTO. BTO and BRENDA are freely accessible for academic users. It can be freely downloaded via the “Ontology Explorer” of the BRENDA website or in the OBO format from “Obofoundry”. BTO (BRENDA Tissue Ontology) BRENDA Ontology Explorer BRENDA-website ExplorEnz – Enzyme Nomenclature Obofoundry Gene Ontology Consortium EBI-EMBL Bioportal des National Center for Biomedical Ontology, Stanford, USA
Sources: en.wikipedia.org
AREs are recognized by RNA binding proteins such as tristetraprolin (TTP), AUF1, and Hu Antigen R (HuR). RNA-binding proteins that bind AREs have been termed ARE-BPs and as of 2019, about 20 ARE-BPs have been identified. Although the exact mechanism is not very well understood, recent publications have attempted to propose the action of some of these ARE-BPs. One characteristic of many ARE-BPs is that they can shuttle between the nucleus and cytoplasm and exert different functions to control gene expression based on their subcellular location. AUF1, also known as hnRNP D, binds AREs through RNA recognition motifs (RRMs). AUF1 is also known to interact with the translation initiation factor eIF4G and with poly(A)-binding protein, indicating that AUF1 senses the translational status of mRNA and decays accordingly through the excision of the poly(A) tail.
81. ArXiv [Preprint]. 2026 Jul 29:arXiv:2605.17186v2. Operator splitting for exploiting linear-rate closure in solving infinite ODE hierarchies. Chang JC. We introduce an operator-splitting method for infinite hierarchies of linear ordinary differential equations (ODEs) indexed by nonnegative integers. When the coupling coefficients depend linearly on the count index, an exact transformation closes the equations on finite count-index windows without an upper-boundary value. For more general hierarchies, Strang splitting applies the linear-rate closure during the linear-rate substeps and a conventional capped solver to the remainder. We derive the closure from generating functions and the method of characteristics and extend it to multi-indexed systems. The derivation requires neither positivity nor mass conservation, so it applies to a wider class of systems than the examplar stochastic models presented here. We discuss branching processes, stochastic predator-prey dynamics, the Schlögl chemical kinetics model, and a telegraph model for gene expression. Through numerical experiments and computational cost analyses we demonstrate that our operator splitting method is typically advantageous for solving large scale systems in terms of memory usage and computational time, while retaining accuracy competitive with finite state projection (FSP) methods. PMCID: PMC13618430
=== Food, supplement, and topical use === In 2024, some 55% of the collagen market in the United States was for use in foods, including such products as sausage casings, thickening agents, preservation methods, and ice cream. Although collagen dietary supplements may be marketed to improve skin elasticity and reduce wrinkles, there is no good evidence that ingestion of collagen has an effect on collagen production or skin health. When consumed by mouth, collagen is digested into its hydrolyzed peptides and amino acids, and therefore the intact collagen product is not incorporated into damaged or wrinkled skin, but possibly its constituents are. Topical skincare products containing intact collagen are advertised to replace or enhance natural skin collagen, but such topical collagen has poor permeability, does not penetrate the skin, and is not absorbed. As of 2025, there is no clinical evidence to support the use of oral collagen supplements or topical products to improve wrinkles or skin aging.
=== Extraction === Extraction is performed with either water or acid solutions at appropriate temperatures. All industrial processes are based on neutral or acid pH values because although alkali treatments speed up conversion, they also promote degradation processes. Acidic extraction conditions are extensively used in the industry, but the degree of acid varies with different processes. This extraction step is a multistage process, and the extraction temperature usually is increased in later extraction steps, which ensures minimum thermal degradation of the extracted gelatin.
Three "File" editions reprinted selected content originally published between 1993 and 1996 in Edge issues 1–36. Each volume of "File" covered 12 issues. "Edge presents... The Art Of Videogames" (2007)
Sources: en.wikipedia.org
Glimepiride is an antidiabetic medication within the sulfonylurea class, primarily prescribed for the management of type 2 diabetes. It is regarded as a second-line option compared to metformin, due to metformin's well-established safety and efficacy. Use of glimepiride is recommended in conjunction with lifestyle modifications such as diet and exercise. It is taken by mouth, reaching a peak effect within three hours and lasting for about a day. Common side effects include headache, nausea, and dizziness. Serious side effects may include low blood sugar. Use during pregnancy and breastfeeding is not recommended. It works predominantly by increasing the amount of insulin released from the pancreas. It is classified as a second-generation sulfonylurea. Glimepiride was patented in 1979 and approved for medical use in 1995. It is available as a generic medication. In 2023, it was the 80th most commonly prescribed medication in the United States, with more than 8 million prescriptions.
Proponents of such an exception have asserted that there is precedent in allowing psychiatrists to speak out when someone presents a clear and present danger. General John Kelly, Trump's second chief of staff, purchased a copy of The Dangerous Case of Donald Trump in an attempt to understand the president's psychoses and consulted it while he was running the White House, which he was known to refer to as "Crazytown." Kelly told others that the book was a helpful guide to a president he came to consider a pathological liar, and mentally ill. In September 2017, Jeanne Suk Gerson wrote in The New Yorker: "A strange consensus does appear to be forming around Trump's mental state", including Democrats and Republicans who doubt Trump's fitness for office. Also in September 2017, journalist Bill Moyers interviewed psychiatrist Robert Jay Lifton and said that Trump "makes increasingly bizarre statements that are contradicted by irrefutable evidence to the contrary". Lifton replied, "He doesn't have clear contact with reality, though I'm not sure it qualifies as a bona fide delusion." As an example, Lifton said, when Trump claimed that former president Barack Obama was born in Kenya, "he was manipulating that lie as well as undoubtedly believing it in part." In September 2017, psychiatrist Jeffrey Lieberman published an article commenting on Donald Trump's mental health. He said that, in accordance with the Goldwater rule, no diagnosis should be made of public figures, but also stated that assessing the president's fitness for government should not be left to politicians alone.
The sponsor designs the trial in coordination with a panel of expert clinical investigators, including what alternative or existing treatments to compare to the new drug and what type(s) of patients might benefit. If the sponsor cannot obtain enough test subjects at one location investigators at other locations are recruited to join the study. During the trial, investigators recruit subjects with the predetermined characteristics, administer the treatment(s) and collect data on the subjects' health for a defined time period. Data include measurements such as vital signs, concentration of the study drug in the blood or tissues, changes to symptoms, and whether improvement or worsening of the condition targeted by the study drug occurs. The researchers send the data to the trial sponsor, who then analyzes the pooled data using statistical tests. Examples of clinical trial goals include assessing the safety and relative effectiveness of a medication or device:
Pantopon, also known as Opium Alkaloids Hydrochlorides, is a preparation of opiates made up of all of the alkaloids present in opium in their natural proportions as hydrochlorides salts. It can sometimes be tolerated by people who are allergic to morphine. Pantopon is prepared by treating standardized medicinal opium with hydrochloric acid or, more commonly, mixing 20 parts morphine HCl, 5 parts codeine, 6 parts thebaine, 8 parts noscapine, 2 parts narcotine, 6 parts miscellaneous alkaloids hydrochlorides. Pantopon is, in other words, opium with all of the tar and other insolubles removed in an injectable form which, by weight, is nearly as potent as morphine. It was invented in 1909 by the Hoffmann-La Roche pharmaceutical company. Other drugs of the same type have included in the opium alkaloid hydrobromides, sulfates, phosphates, and valerates. "Opium in a syringe " and "Injectable Whole Opium" were common advertising slogans for the product from Roche. An example of similar product to Pantopon is Omnopon, which contains morphine, codeine, and papaverine.
== With herbal medicines == Herb-drug interactions are drug interactions that occur between herbal medicines and conventional drugs. These types of interactions may be more common than drug-drug interactions because herbal medicines often contain multiple pharmacologically active ingredients, while conventional drugs typically contain only one. Some such interactions are clinically significant, although most herbal remedies are not associated with drug interactions causing serious consequences. Most catalogued herb-drug interactions are moderate in severity. The most commonly implicated conventional drugs in herb-drug interactions are warfarin, insulin, aspirin, digoxin, and ticlopidine, due to their narrow therapeutic indices. The most commonly implicated herbs involved in such interactions are those containing St. John's Wort, magnesium, calcium, iron, or ginkgo.
Sources: en.wikipedia.org
No single time applies to all peptides. Storage life depends on sequence, solvent, concentration, and temperature. Stability should be determined experimentally or taken from supplier data for the specific lot.
Refreezing is possible but repeated cycles are discouraged. Each freeze-thaw step may increase aggregation or loss. Aliquoting before freezing reduces the number of cycles.
Cloudiness, visible particles, color changes, or new peaks in chromatography can indicate degradation. A loss of expected activity in an assay may also suggest a problem. Confirmatory methods include LC-MS and purity analysis.
Refrigeration is common for short-term use, while freezing at -20 °C or -80 °C is common for longer periods. Aliquots reduce repeated temperature changes. Exact conditions depend on the peptide and buffer.